Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Elevation Oncology Inc’s current trading price is -95.55% away from its 52-week high, while its distance from the 52-week low is 7.63%. The stock’s price range over this period has fluctuated between $0.24 and $5.83. The company, operating within the financial sector, had a trading volume of approximately 1.44 million for the day, which was noticeably lower than the average daily share volume of 2.6 million over the last 3 months.
Elevation Oncology Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $5.83 on 04/03/24 and the lowest value was $0.24 on 03/20/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Elevation Oncology Inc (ELEV) has experienced a quarterly decline of -54.50% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 15.36M and boasts a workforce of 34 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.5803, with a change in price of -0.2948. Similarly, Elevation Oncology Inc recorded 1,915,949 in trading volume during the last 100 days, posting a change of -52.64%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ELEV stands at 0.52. Similarly, the long-term debt-to-equity ratio is also 0.52.
ELEV Stock Stochastic Average
Today, Elevation Oncology Inc’s raw stochastic average for the past 50 days stands at 4.39%, indicating a decline from the raw stochastic average of the last 20 days, which was 7.93%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 5.33% and 5.36% respectively.
ELEV Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant loss of -53.89% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -56.76%. Over the past 30 days, the price of ELEV has leaped by -46.66%. And in the last five days, it has fallen by -1.41%.
